Publications by Wim Van Criekinge.

2017

A four-gene promoter methylation marker panel consisting of GREM1, NEURL, LAD1, and NEFH predicts survival of clear cell renal cell cancer patients
I. van Vlodrop, S. Joosten, T. De Meyer, K. Smits, L. Van Neste, V. Melotte, M. Baldewijns, L. Schouten, P. van den Brandt, J. Jeschke, J. Yi, K. Schuebel, N. Ahuja, J. Herman, M. Aarts, F. Bosman, W. Van Criekinge and M. van Engeland
(2017) CLINICAL CANCER RESEARCH, 23,

Epigenetic sampling effects : nephrectomy modifies the clear cell renal cell cancer methylome
C. Van Neste, A. Laird, F. O’Mahony, W. Van Criekinge, D. Deforce, F. Van Nieuwerburgh, T. Powles, D. Harrison, G. Stewart and T. De Meyer
(2017) CELLULAR ONCOLOGY, 40,

Methylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancer
T. Tomar, N. Alkema, L. Schreuder, G. Meersma, T. De Meyer, W. Van Criekinge, H. Klip, H. Fiegl, E. van Nieuwenhuysen, I. Vergote, M. Widschwendter, E. Schuuring, A. van der Zee, S. de Jong and G. Wisman
(2017) BMC MEDICINE, 15, 116

A urinary biomarker-based risk score correlates with multiparametric MRI for prostate cancer detection
R. Hendriks, M. van der Leest, S. Dijkstra, J. Barentsz, W. Van Criekinge, C. Hulsbergen-van de Kaa, J. Schalken, P. Mulders and I. van Oort
(2017) PROSTATE, 77,

Novel stool-based protein biomarkers for improved colorectal cancer screening : a case-control study
L. Bosch, M. de Wit, T. Pham, V. Coupe, A. Hiemstra, S. Piersma, G. Oudgenoeg, G. Scheffer, S. Mongera, J. Droste, F. Oort, S. van Turenhout, I. Ben Larbi, J. Louwagie, W. Van Criekinge, R. van der Hulst, C. Mulder, B. Carvalho, R. Fijneman, C. Jimenez and G. Meijer
(2017) ANNALS OF INTERNAL MEDICINE, 167,

Differential analysis of genome-wide methylation and gene expression in mesenchymal stem cells of patients with fractures and osteoarthritis
A. del Real, F. Pérez-Campo, A. Fernández, C. Sañudo, C. Ibarbia, M. Pérez-Núñez, W. Van Criekinge, M. Braspenning, M. Alonso, M. Fraga and J. Riancho
(2017) EPIGENETICS, 12,

Genome-wide DNA methylation profiling reveals methylation markers associated with 3q gain for detection of cervical precancer and cancer
W. Verlaat, P. Snijders, P. Novianti, S. Wilting, L. De Strooper, G. Trooskens, J. Vandersmissen, W. Van Criekinge, G. Wisman, C. Meijer, D. Heideman and R. Steenbergen
(2017) CLINICAL CANCER RESEARCH, 23,

Epigenetic risk score improves prostate cancer risk assessment
L. Van Neste, J. Groskopf, W. Grizzle, G. Adams, M. DeGuenther, P. Kolettis, J. Bryant, G. Kearney, M. Kearney, W. Van Criekinge and S. Gaston
(2017) PROSTATE, 77,

The microbiome in posttraumatic stress disorder and trauma-exposed controls : an exploratory study
S. Hemmings, S. Malan-Müller, L. van den Heuvel, B. Demmitt, M. Stanislawski, D. Smith, A. Bohr, C. Stamper, E. Hyde, J. Morton, C. Marotz, P. Siebler, M. Braspenning, W. Van Criekinge, A. Hoisington, L. Brenner, T. Postolache, M. McQueen, K. Krauter, R. Knight, S. Seedat and C. Lowry
(2017) PSYCHOSOMATIC MEDICINE, 79,

Cost-effectiveness of a new urinary biomarker-based risk score compared to standard of care in prostate cancer diagnostics : a decision analytical model
S. Dijkstra, T. Govers, R. Hendriks, J. Schalken, W. Van Criekinge, L. Van Neste, J. Grutters, J. Sedelaar and I. van Oort
(2017) BJU INTERNATIONAL, 120,